Pharmarise Holdings Corporation (TYO:2796)
Japan
· Delayed Price · Currency is JPY 481.00
+1.00 (0.21%)
Jun 3, 2025, 3:30 PM JST
Pharmarise Holdings Revenue
Pharmarise Holdings had revenue of 16.04B JPY in the quarter ending February 28, 2025, with 16.82% growth. This brings the company's revenue in the last twelve months to 60.37B, up 11.85% year-over-year. In the fiscal year ending May 31, 2024, Pharmarise Holdings had annual revenue of 54.47B with 4.68% growth.
Revenue (ttm)
60.37B
Revenue Growth
+11.85%
P/S Ratio
0.09
Revenue / Employee
32.67M
Employees
1,848
Market Cap
5.45B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| May 31, 2024 | 54.47B | 2.44B | 4.68% |
| May 31, 2023 | 52.03B | 422.00M | 0.82% |
| May 31, 2022 | 51.61B | -716.00M | -1.37% |
| May 31, 2021 | 52.32B | 1.29B | 2.54% |
| May 31, 2020 | 51.03B | -698.00M | -1.35% |
| May 31, 2019 | Pro | Pro | Pro |
| May 31, 2018 | Pro | Pro | Pro |
| May 31, 2017 | Pro | Pro | Pro |
| May 31, 2016 | Pro | Pro | Pro |
| May 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,222.12B |
| Daiichi Sankyo Company | 1,886.26B |
| Takeda Pharmaceutical Company | 4,581.55B |
| HOYA Corporation | 869.37B |
| Terumo | 1,036.17B |
| Otsuka Holdings | 2,393.18B |
| Astellas Pharma | 1,912.32B |
| Olympus | 997.33B |